The Licensing Executives Society Silicon Valley Chapter will be holding a luncheon event on IP Transactional Intermediaries: Who are they and what do they do? will be held on October 25, 2006 from 11:30-1:30 at Benson Parlor at Santa Clara University. The speakers include Ron Epstein, CEO of IPotential, and David Smith, Founder of TYNAX.
Category:
Biotech Industry Events |
Comments Off on IP Transactional Intermediaries:Who are they and what do they do?”
The event Connecting People to Company Success will take place on October 25, 2006 from 7:30 – 9:30 a.m. at the Radisson Hotel La Jolla, 3299 Holiday Court, in La Jolla, CA. For more information, contact Joanna Cuevas at (858) 882-8033 or jccuevas@ucsd.edu.
The event Hands-on Bioinformatics Computer Workshop will take place on October 25, 2006 at OpenHelix, LLC in San Francisco, CA. This is a hands-on computer workshop sponsored by the UCSC Bioinformatics Group. The introductory tutorial will cover the topics needed to effectively use the powerful, free, publicly-accessible UCSC Genome Browser tool, including: basic functionality of Genome Browser searching and BLAT use, Table Browser use, creating and using Custom Tracks, and an introduction to the Gene Sorter. For more information, contact nsirohi@openhelix.com.
The event Extraterritoriality: Divided Claims, Divided Lands will take place on October 25, 2006 at 275 Middlefield Road, in Menlo Park, CA. The discussion relates to the extraterritorial application of U.S. patent law, multiple party/divided claim issues and extraterritoriality and associated planning issues.
The 7th Annual Early Stage Investing Conference will take place on October 24-25, 2006 at The San Jose Marriot, San Jose, CA. This conference affords an atmosphere where the community as a whole can expand their knowledge base and network with Venture capital industry leaders on how they are adjusting their activities and plans in this promising venture capital market. The participants in this event include Advisory Board Chairman Terry L. Opdendyk, General Partner, NSET Ventures; Conference Chairman Vincent M. Occhipinti, Managing Director Woodside Fund; and Advisory Board Members Mark Perry, General Partner, New Enterprise Associates; Ravi Mohan, General Partner, Shasta Ventures;
Bob Williams, General Partner, Bay Partners; Kip Sheeline, General Partner, Levensohn Venture Partners; Ajit Nazre, Partner, Kleiner Perkins Caufield & Byers; and Gary Little, General Partner, Morgenthaler Ventures. For more information, contact IBF (Cathy Fenn) at (516) 765-9005, Ext. 21 or e-mail: cathy@ibfconferences.com.
The event New Funding Opportunities for Small Businesses will take place on October 24, 2006 from 10:00 a.m. – 12:00 p.m. at the San Diego Marriott La Jolla, in La Jolla, CA. NCI SBIR & STTR Director Michael Weingarten will discuss funding opportunities available to small businesses to support research and development in the areas of anti-cancer agents, biomarkers, nanotechnology, proteomics, pharmacodynamics, and many more areas of interest to the NCI. In addition, Dr. Piotr Grodzinski will present an overview of the NCI Alliance for Nanotechnology in Cancer.
The event the 3rd Global Pharma R&D Summit will take place from October 23-25, 2006 at the Anaheim Marriott in Anaheim, CA. This world-class conference brings together up to 300 leading Drug Discovery & Development professionals. Topics include: the future role of the FDA, pandemics, personalized medicine, biomarkers, and nanobiotechnology. Confirmed speakers include Dr. Andrew von Eschenbach, Acting Commissioner, Food and Drug Administration; Dr. Edward Abrahams, Executive Director, Personalized Medicine Coalition; Dr. Klaus St
The event the 3rd Global Pharma R&D Summit will take place from October 23-25, 2006 at the Anaheim Marriott in Anaheim, CA. This world-class conference brings together up to 300 leading Drug Discovery & Development professionals. Topics include: the future role of the FDA, pandemics, personalized medicine, biomarkers, and nanobiotechnology. Confirmed speakers include Dr. Andrew von Eschenbach, Acting Commissioner, Food and Drug Administration; Dr. Edward Abrahams, Executive Director, Personalized Medicine Coalition; Dr. Klaus St
The 8th Annual Nobel Science and Appreciation Gala will take place on October 21, 2006 from 6:00 p.m. to 9:00 p.m. at the Hyatt Regency La Jolla. The event will be co-hosted in partnership with BIOCOM and the Life Sciences Summer Institute, and in conjunction with the Consulate of Sweden, and will honor the region’s scientificexcellence. For additional information, contact Shaye Testagrossa at stesta@biocom.org or 858-455-0300.
Session IX of the 2006 Women’s Technolgy Cluster Catalyst Program, Term Sheet Negotiation, will take place on October 20, 2006 from 8 to 10:15 a.m. at Fenwick & West LLP’s office at 801 California Street, Mountain View, CA. The speakers for this event will be Christine Herron, Omidyar Network; Cindy Padnos, Outlook Ventures; and Rob Dellenbach, Fenwick & West. The event will prepare early stage companies for the negotiation of a term sheet in the final stages of securing funding. Registration is $27.17 (the registration price for the full series is $172.00).
Category:
Biotech Industry Events |
Comments Off on 2006 Women’s Technology Cluster Catalyst Program: Session IX–Term Sheet Negotiation